Pathogenesis of Depression in Alzheimer's Disease

被引：4

作者：

Zhan, Qingyang ^{[1
]}

Kong, Fanyi ^{[1
]}

Shao, Shuai ^{[1
]}

Zhang, Bo ^{[1
]}

Huang, Shuming ^{[1
]}

机构：

[1] Heilongjiang Univ Chinese Med, Inst Chinese Med, Harbin 150040, Peoples R China

来源：

NEUROCHEMICAL RESEARCH | 2024年 / 49卷 / 03期

基金：

中国国家自然科学基金;

关键词：

Alzheimer's Disease; Depression; Serotonin; Neuro-inflammation; HPA axis; BDNF; Glutamate; Hippocampal atrophy; AMYLOID-BETA OLIGOMERS; LONG-TERM DEPRESSION; D-ASPARTATE RECEPTOR; NEUROTROPHIC FACTOR; OLDER-ADULTS; MOUSE MODEL; HIPPOCAMPAL; DOPAMINE; NEUROGENESIS; DYSFUNCTION;

D O I：

10.1007/s11064-023-04061-0

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Depression is a prevalent occurrence among Alzheimer's disease (AD) patients, yet its underlying mechanism remains unclear. Recent investigations have revealed that several pathophysiological changes associated with Alzheimer's disease can lead to mood disorders. These alterations include irregularities in monoamine neurotransmitters, disruptions in glutamatergic synaptic transmission, neuro-inflammation, dysfunction within the hypothalamic-pituitary-adrenocortical (HPA) axis, diminished levels of brain-derived neurotrophic factor (BDNF), and hippocampal atrophy. This review consolidates research findings from pertinent fields to elucidate the mechanisms underlying depression in Alzheimer's disease, aiming to provide valuable insights for the study of its mechanisms and clinical treatment.

引用

页码：548 / 556

页数：9

共 50 条

[31] Depression and Alzheimer's Disease Biomarkers Predict Driving Decline
Babulal, Ganesh M.
Chen, Suzie
Williams, Monique M.
Trani, Jean-Francois
Bakhshi, Parul
Chao, Grace L.
Stout, Sarah H.
Fagan, Anne M.
Benzinger, Tammie L. S.
Holtzman, David M.
Morris, John C.
Roe, Catherine M.
JOURNAL OF ALZHEIMERS DISEASE, 2018, 66 (03) : 1213 - 1221
[32] Major depression, cognitive dysfunction and Alzheimer's disease: Is there a link?
Sierksma, Annerieke S. R.
van den Hove, Daniel L. A.
Steinbusch, Harry W. M.
Prickaerts, Jos
EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 626 (01) : 72 - 82
[33] Serotonin 6 receptor controls alzheimer's disease and depression
Yun, Hyung-Mun
Park, Kyung-Ran
Kim, Eun-Cheol
Kim, Sanghyeon
Hong, Jin Tae
ONCOTARGET, 2015, 6 (29) : 26716 - 26728
[34] Role of Serotonylation and SERT Posttranslational Modifications in Alzheimer's Disease Pathogenesis
Reddy, Arubala P.
Rawat, Priyanka
Rohr, Nicholas
Alvir, Razelle
Bisht, Jasbir
Bushra, Mst Anika
Luong, Jennifer
Reddy, Aananya P.
AGING AND DISEASE, 2024, : 841 - 858
[35] Targeting Microglia in Alzheimer's Disease: Pathogenesis and Potential Therapeutic Strategies
Sun, Zhongqing
Zhang, Xin
So, Kwok-Fai
Jiang, Wen
Chiu, Kin
BIOMOLECULES, 2024, 14 (07)
[36] Recognizing Alzheimer's disease from perspective of oligodendrocytes: Phenomena or pathogenesis?
Wang, Jingji
Zhen, Yilan
Yang, Jun
Yang, Shaojie
Zhu, Guoqi
CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (03)
[37] Alzheimer's disease: from early pathogenesis to novel therapeutic approaches
Prajapati, Santosh Kumar
Pathak, Arjit
Samaiya, Puneet K.
METABOLIC BRAIN DISEASE, 2024, 39 (06) : 1231 - 1254
[38] Pharmacological Treatment of Depression in Alzheimer's Disease: A Challenging Task
Cassano, Tommaso
Calcagnini, Silvio
Carbone, Antonio
Bukke, Vidyasagar Naik
Orkisz, Stanislaw
Villani, Rosanna
Romano, Adele
Avolio, Carlo
Gaetani, Silvana
FRONTIERS IN PHARMACOLOGY, 2019, 10
[39] Key brain cell interactions and contributions to the pathogenesis of Alzheimer's disease
Saavedra, Joana
Nascimento, Mariana
Liz, Marcia A.
Cardoso, Isabel
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
[40] Integrated Biomarkers for Depression in Alzheimer's Disease: A Critical Review
Wenzler, Sofia
Knoechel, Christian
Balaban, Ceylan
Kraft, Dominik
Kopf, Juliane
Alves, Gilberto S.
Prvulovic, David
Carvalho, Andre F.
Oertel-Knoechel, Viola
CURRENT ALZHEIMER RESEARCH, 2017, 14 (04) : 441 - 452

← 1 2 3 4 5 →